Nobuyuki Yasuda,Kiyoshi Oketani,Hiroko Baba,Tomohisa Nakano,Masahiko Mori
申请号：
US15951321
公开号：
US20180303933A1
申请日:
2018.04.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
It is an object of the present invention to provide a pharmaceutical composition comprising an anti-fractalkine antibody that provides therapeutically effective improvement to Crohns disease, after the administration thereof to a human subject, and a method for treating Crohns disease. Provided is a pharmaceutical composition for treating Crohns disease. The present pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient, and is used, such that the anti-fractalkine antibody is intravenously administered to a human at a dose of at least 10 mg/kg of human body weight in a method for treating Crohns disease.
